Determinants of highly active antiretroviral therapy duration in HIV-1-infected children and adolescents in Madrid, Spain, from 1996 to 2012

Detalhes bibliográficos
Autor(a) principal: Palladino, Claudia
Data de Publicação: 2014
Outros Autores: Briz, Verónica, Bellón, José María, Climent, Francisco J., De Ory, Santiago J., Mellado, María José, Navarro, María Luisa, Ramos, José T., Taveira, Nuno, De José, María Isabel, Muñoz-Fernández, María Ángeles, CoRISpeS-Madrid Cohort Working Group
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10451/62087
Resumo: © 2014 Palladino et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
id RCAP_6c473623926e3dc495ecbfb0a8cc405a
oai_identifier_str oai:repositorio.ul.pt:10451/62087
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Determinants of highly active antiretroviral therapy duration in HIV-1-infected children and adolescents in Madrid, Spain, from 1996 to 2012© 2014 Palladino et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.Objectives To investigate the duration of sequential HAART regimens and predictors of first-line regimen discontinuation among HIV-1 vertically infected children and adolescents. Design Multicentre survey of antiretroviral-naïve patients enrolled in the HIV-Paediatric Cohor,t CoRISpeS-Madrid Cohort, Spain. Methods Patients with a follow-up of ≥1 month spent on HAART, with available baseline CD4 count and HIV-viral load (VL) were included. Time spent on sequential HAART regimens was estimated and multivariable regression was used to identify predictors of time to first-line regimen discontinuation. Results 104 patients were followed for a median 8 years after starting HAART among 1996–2012; baseline %CD4 was 21.5 (12.3–34.0)and viral load was 5.1 (4.6–5.6) log10 copies/mL. Patients received a mean of 1.9 regimens. Median time on first-line HAART (n = 104) was 64.5 months; second HAART (n = 56) 69.8 months; and third HAART (n = 21) 66.5 months. Eleven (11%) patients were lost to follow-up while on first-line HAART and 54% discontinued (cumulative incidence of 16% and 38% by 1 and 3-year, respectively). The main predictor of first-line regimen discontinuation was suboptimal adherence to antiretrovirals (AHR: 2.60; 95% CI: 1.44–4.70). Conclusions Adherence to therapy was the main determinant of the duration of the first-line HAART regimen in children. It is important to identify patients at high risk for non-adherence, such as very young children and adolescents, in provide special care and support to those patients.This work was supported by grants provided by the Fondo de Investigación de Sanidad en España (FIS) [grant numbers PI11-00888, PS09/02029, and PI13/02016], Red Española de Investigación en SIDA (RIS) [grant numbers RETIC RD06/0006/0035 RD12-0017-0037; RD06/0006/0021, RD12/0017/0029 and RD09/0076/00103], “Fundación para la Investigación y la Prevención del Sida en España” (FIPSE), Comunidad de Madrid [grant numbers, S-2010/BMD-2351, S-2010/BMD-2332], PENTA and Fundación Eugenio Rodríguez Pascual and grants PTDC/SAU-FAR/115290/2009 and PTDC/SAU-EPI/122400/2010 from Fundação para a Ciência e Tecnologia (FCT) (http://www.fct.pt), Portugal. Claudia Palladino is supported by the Portuguese Fundação para a Ciência e Tecnologia (FCT) (SFRH/BPD/77448/2011). Verónica Briz is supported by the Spanish Fondo de Investigación Sanitaria (Sara Borrell CD09/00433. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.PLoSRepositório da Universidade de LisboaPalladino, ClaudiaBriz, VerónicaBellón, José MaríaCliment, Francisco J.De Ory, Santiago J.Mellado, María JoséNavarro, María LuisaRamos, José T.Taveira, NunoDe José, María IsabelMuñoz-Fernández, María ÁngelesCoRISpeS-Madrid Cohort Working Group2024-01-24T19:11:48Z20142023-02-09T15:17:38Z2014-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10451/62087engPalladino C, Briz V, Bellón JM, Climent FJ, De Ory SJ, Mellado MJ, et al. Determinants of highly active antiretroviral therapy duration in hiv-1-infected children and adolescents in madrid, spain, from 1996 to 2012. He W, editor. PLoS ONE [Internet]. 1 de maio de 2014;9(5):e96307. Disponível em: https://dx.plos.org/10.1371/journal.pone.0096307cv-prod-118553210.1371/journal.pone.00963072-s2.0-84900338272info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-01-29T01:19:33Zoai:repositorio.ul.pt:10451/62087Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T01:58:28.925399Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Determinants of highly active antiretroviral therapy duration in HIV-1-infected children and adolescents in Madrid, Spain, from 1996 to 2012
title Determinants of highly active antiretroviral therapy duration in HIV-1-infected children and adolescents in Madrid, Spain, from 1996 to 2012
spellingShingle Determinants of highly active antiretroviral therapy duration in HIV-1-infected children and adolescents in Madrid, Spain, from 1996 to 2012
Palladino, Claudia
title_short Determinants of highly active antiretroviral therapy duration in HIV-1-infected children and adolescents in Madrid, Spain, from 1996 to 2012
title_full Determinants of highly active antiretroviral therapy duration in HIV-1-infected children and adolescents in Madrid, Spain, from 1996 to 2012
title_fullStr Determinants of highly active antiretroviral therapy duration in HIV-1-infected children and adolescents in Madrid, Spain, from 1996 to 2012
title_full_unstemmed Determinants of highly active antiretroviral therapy duration in HIV-1-infected children and adolescents in Madrid, Spain, from 1996 to 2012
title_sort Determinants of highly active antiretroviral therapy duration in HIV-1-infected children and adolescents in Madrid, Spain, from 1996 to 2012
author Palladino, Claudia
author_facet Palladino, Claudia
Briz, Verónica
Bellón, José María
Climent, Francisco J.
De Ory, Santiago J.
Mellado, María José
Navarro, María Luisa
Ramos, José T.
Taveira, Nuno
De José, María Isabel
Muñoz-Fernández, María Ángeles
CoRISpeS-Madrid Cohort Working Group
author_role author
author2 Briz, Verónica
Bellón, José María
Climent, Francisco J.
De Ory, Santiago J.
Mellado, María José
Navarro, María Luisa
Ramos, José T.
Taveira, Nuno
De José, María Isabel
Muñoz-Fernández, María Ángeles
CoRISpeS-Madrid Cohort Working Group
author2_role author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório da Universidade de Lisboa
dc.contributor.author.fl_str_mv Palladino, Claudia
Briz, Verónica
Bellón, José María
Climent, Francisco J.
De Ory, Santiago J.
Mellado, María José
Navarro, María Luisa
Ramos, José T.
Taveira, Nuno
De José, María Isabel
Muñoz-Fernández, María Ángeles
CoRISpeS-Madrid Cohort Working Group
description © 2014 Palladino et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
publishDate 2014
dc.date.none.fl_str_mv 2014
2014-01-01T00:00:00Z
2023-02-09T15:17:38Z
2024-01-24T19:11:48Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10451/62087
url http://hdl.handle.net/10451/62087
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Palladino C, Briz V, Bellón JM, Climent FJ, De Ory SJ, Mellado MJ, et al. Determinants of highly active antiretroviral therapy duration in hiv-1-infected children and adolescents in madrid, spain, from 1996 to 2012. He W, editor. PLoS ONE [Internet]. 1 de maio de 2014;9(5):e96307. Disponível em: https://dx.plos.org/10.1371/journal.pone.0096307
cv-prod-1185532
10.1371/journal.pone.0096307
2-s2.0-84900338272
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv PLoS
publisher.none.fl_str_mv PLoS
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799137069439647744